Skip to main content
Caplight Logo









Ultrahuman

Ultrahuman

Private
BangaloreConsumer & Commercehttps://ultrahuman.com

Last Round

Series C

Sep 3, 2026

Est. Valuation

$363M

Total Funding Raised

$195M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Ultrahuman is a health technology company that develops and manufactures wearable devices and platforms for metabolic health, fitness, and sleep monitoring.

Sector

Consumer & Commerce

Verticals

Consumer Electronics, Sports & Fitness, Health IoT, Subscription Commerce, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales, Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

smart ringwearable devicecontinuous glucose monitoringCGMbiohackingmetabolic healthhealth trackingsleep trackingred light therapyhealth coachingpersonalized wellnessAI health coachbiointelligencewellness dataDTC health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ultrahuman Comparables

Compare Ultrahuman with similar companies based on industry and business-model similarity.

Ultrahuman comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Levels
83%
Oura
83%
Noise
82%

Ultrahuman Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CSep 3, 2026
Series C ExtensionJul 15, 2026
Series CMar 17, 2026
DebtNov 20, 2025
Early FundingApr 28, 2025
Debt
Mar 20, 2024

Key People

Founding team and executive leadership

Ishani Shrivastava

Program Manager, CEO S Office

Executive Team

Mohit Kumar

Founder and CEO - Ultrahuman

Founding Team

Yogesh Mittal

Group Chief Financial Officer

Executive Team

Bhuvan Srinivasan

Board Member, Chief Business Officer

Executive Team

Ultrahuman Investors

Notable investors and investment history

Ultrahuman investors
InvestorRounds
Alteria CapitalDebt, Series C
Steadview CapitalSeries A, Series B, Series C Extension
Rainmatter Capital FundSeries A Extension
iSeedSeries A
Qualcomm VenturesSeries C
Panthera Capital InvestmentsSeries B
Blume VenturesDebt, Series C, Series A, Seed, Series B, Series C Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2026

    $70M round led by Qualcomm Ventures

  • Jul 15, 2026

    $60M round led by Steadview Capital and Blume Ventures.

Recent news

Latest coverage and updates

  • has_issues_withOct 24, 2026

    Oura's latest Texas federal lawsuit claims Ultrahuman Healthcare Pvt Ltd.'s redesigned Ring Pro still infringes design and hardware patents; Ultrahuman Healthcare Pvt Ltd. says the ring remains available in the United States and plans to contest the allegations.

  • has_issues_withOct 23, 2026

    Oura says Ultrahuman Healthcare Pvt Ltd. infringes patents covering the Ring Pro’s curved battery, circuit board, magnets, and sensors, and files suit on Oct 22nd '26.

  • has_issues_withOct 23, 2026

    Ultrahuman Healthcare Pvt Ltd. faces Oura’s claim that its redesigned Ring Pro fails to fix ongoing patent violations involving the ring’s physical design and internal components.

  • has_issues_withOct 23, 2026

    Ultrahuman Healthcare Pvt Ltd. faces a new lawsuit in Texas in which Oura alleges that its Ring Pro infringes on two of Oura's patents on Oct 23rd '26.

  • has_issues_withOct 23, 2026

    On Oct 23rd '26 in Texas, Oura files a complaint against Ultrahuman Healthcare Pvt Ltd. alleging patent infringement and claims its modified ring still incorporates Oura's patented innovations.

Ultrahuman Filings

Explore SEC and related filing metadata, where available.

Ultrahuman filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ultrahuman's valuation, stock price, and market status.

Is Ultrahuman a public or private company?

Ultrahuman is a private company.

What is the current stock price of Ultrahuman?

Ultrahuman is a private company, so its shares have no public market price. Caplight tracks Ultrahuman's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ultrahuman worth (valuation)?

Ultrahuman's valuation is estimated at $363.0M based on funding round data.

Can I buy Ultrahuman stock?

Ultrahuman shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ultrahuman's last funding round?

Ultrahuman's most recent funding round was Series C on September 3, 2026.

Who are the main investors in Ultrahuman?

Key investors in Ultrahuman include Steadview Capital, Qualcomm Ventures, Blume Ventures, WestBridge Capital, Nexus Venture Partners.

Will Ultrahuman IPO soon?

No public IPO plans have been announced for Ultrahuman.

How can I track Ultrahuman secondary market activity?

Caplight tracks bids, offers, and trades in Ultrahuman's shares on secondary markets.

Firmographic Details

HeadquartersBangalore
Employee Range393
Year Founded2019
Last FundingSep 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?